Literature DB >> 27633817

Role of belly board device in the age of intensity modulated radiotherapy for pelvic irradiation.

Neil C Estabrook1, Gregory K Bartlett1, Julia J Compton1, Higinia R Cardenes1, Indra J Das2.   

Abstract

Small bowel dose often represents a limiting factor for radiation treatment of pelvic malignancies. To reduce small bowel toxicity, a belly board device (BBD) with a prone position is often recommended. Intensity modulated radiotherapy (IMRT) could reduce dose to small bowel based on the desired dose-volume constraints. We investigated the efficacy of BBD in conjunction with IMRT. A total of 11 consecutive patients with the diagnosis of rectal cancer, who were candidates for definitive therapy, were selected. Patients were immobilized with BBD in prone position for simulation and treatment. Supine position computed tomography (CT) data were either acquired at the same time or during a diagnostic scan, and if existed was used. Target volumes (TV) as well as organs at risk (OAR) were delineated in both studies. Three-dimensional conformal treatment (3DCRT) and IMRT plans were made for both scans. Thus for each patient, 4 plans were generated. Statistical analysis was conducted for maximum, minimum, and mean dose to each structure. When comparing the normalized mean Gross TV dose for the different plans, there was no statistical difference found between the planning types. There was a significant difference in small bowel sparing when using prone position on BBD comparing 3DCRT and IMRT plans, favoring IMRT with a 29.6% reduction in dose (p = 0.007). There was also a statistically significant difference in small bowel sparing when comparing supine position IMRT to prone-BBD IMRT favoring prone-BBD IMRT with a reduction of 30.3% (p = 0.002). For rectal cancer when small bowel could be a limiting factor, prone position using BBD along with IMRT provides the best sparing. We conclude that whenever a dose escalation in rectal cancer is desired where small bowel could be limiting factor, IMRT in conjunction with BBD should be selected.
Copyright © 2016 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Belly board device; IMRT; Rectal cancer; Small bowel toxicity

Mesh:

Year:  2016        PMID: 27633817     DOI: 10.1016/j.meddos.2016.07.002

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  3 in total

Review 1.  A critical literature review on the use of bellyboard devices to control small bowel dose for pelvic radiotherapy.

Authors:  Matthew Hoffmann; Kim Waller; Andrew Last; Justin Westhuyzen
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-19

Review 2.  Radiotherapy based management during Covid-19 pandemic - A systematic review of presented consensus and guidelines.

Authors:  Zahra Siavashpour; Neda Goharpey; Mosayyeb Mobasheri
Journal:  Crit Rev Oncol Hematol       Date:  2021-06-30       Impact factor: 6.312

3.  Effect of prone and supine treatment positions for postoperative treatment of rectal cancer on target dose coverage and small bowel sparing using intensity-modulated radiation therapy.

Authors:  Yongqiang Yang; Shang Cai; Tianshu Zhao; Qiliang Peng; Jianjun Qian; Ye Tian
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.